1. Home
  2. PIII vs BGLC Comparison

PIII vs BGLC Comparison

Compare PIII & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo P3 Health Partners Inc.

PIII

P3 Health Partners Inc.

HOLD

Current Price

$2.82

Market Cap

10.0M

Sector

Health Care

ML Signal

HOLD

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$2.44

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PIII
BGLC
Founded
2015
2017
Country
United States
Malaysia
Employees
360
N/A
Industry
Medical/Nursing Services
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
10.1M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PIII
BGLC
Price
$2.82
$2.44
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$16.25
N/A
AVG Volume (30 Days)
100.9K
8.1K
Earning Date
03-26-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.78
EPS
N/A
N/A
Revenue
N/A
$9,510,646.00
Revenue This Year
N/A
N/A
Revenue Next Year
$14.85
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.23
52 Week High
$11.30
$15.19

Technical Indicators

Market Signals
Indicator
PIII
BGLC
Relative Strength Index (RSI) 52.47 47.96
Support Level $1.52 $2.12
Resistance Level $2.85 $2.73
Average True Range (ATR) 0.53 0.15
MACD 0.02 0.04
Stochastic Oscillator 30.81 52.51

Price Performance

Historical Comparison
PIII
BGLC

About PIII P3 Health Partners Inc.

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: